IFFIm - the International Finance Facility for Immunisation

When it comes to measuring efficacy, where, when and how you give malaria vaccines matters. (IFFIm supports Gavi, the Vaccine Alliance's malaria programmes with more than US$ 10 million in funding).

Amid fuel shortages and power cuts, Burundi’s health system battles to adapt – and deliver measles vaccinations to at-risk children. IFFIm is supporting Gavi, the Vaccine Alliance's measles programmes with nearly US$ 200 million in funding. https://lnkd.in/e8_K2f_Q

Here's the latest good news about malaria vaccines. IFFIm supports Gavi, the Vaccine Alliance malaria programmes with more than US$ 10 million in funding.

Having recorded a staggering 140,821 cases of measles in 1975, Ghana saw just 88 cases in 2023. Read more about how routine immunisation is having an impact. (IFFIm has disbursed US$ 189 million to Gavi to fight the measles): https://lnkd.in/eBjk9zPv

IFFIm welcomes three new members to our Board of Directors. Eila Kreivi and Rachel Turner CBE join the Board on 1 July; Jeffrey R. Diehl assumes his role on 1 September. We are looking forward to working with them! Read more:

So far, IFFIm’s donors and investors have helped Gavi, the Vaccine Alliance protect over a billion children against deadly diseases. As we look to the future, we aim to ensure every child, everywhere has access to life-saving vaccines—and to immunise 500 million children, saving over 8 million lives between 2026 and 2030. Funding IFFIm is integral to Gavi’s 6.0 replenishment efforts. To deliver on its ambitious plan, Gavi is seeking at least US$ 9 billion in additional resources for the period 2026–2030, including US$ 1.7 billion of flexible, long-term funding financed through commitments to IFFIm. IFFIm’s proven model, underpinned by new donor pledges, will enable Gavi 6.0 to: • Frontload large-scale funding for the rapid introductions and scale-up of new and existing vaccines, such as malaria, hexavalent and HPV • Forge long-term commitments with manufacturers, securing supplies and reducing prices • Provide surge funding to respond to unexpected events, such as future outbreaks and pandemics • Deliver time-flexible funding to adapt to the changing timing of vaccine introductions and campaigns and maximise the reach to zero-dose children • Accelerate funding to help countries strengthen and sustain critical health systems Acting together, now is the time to harness the power of this unique and innovative Alliance to save lives, strengthen and accelerate global health outcomes, and protect our future. Read more about Gavi’s investment opportunity and how IFFIm will be part of it:

Investments in immunisation are investments in healthier futures for children around the world. The case for world leaders is clear: we need to fully fund Gavi, the Vaccine Alliance – and contributions from sovereign donors through IFFIm will help meet that goal. #ForOurFuture

We are getting ready to participate in tomorrow's Protecting Our Future forum in Paris. Here are five key reasons why the world needs to invest in vaccines, now more than ever:

IFFIm Board Chair Ken Lay will speak this week at the Invisso Global Borrowers & Bond Investors Forum on “The move to focused impact in the debt capital markets.”  Ken and Michael Bennett will be discussing the increasing interest in transactions such as those that carry results-based returns and/or offer a “pure play” in use of proceeds such as IFFIm. 

IFFIm has helped Gavi save millions of lives by providing one-sixth of Gavi's overall budget. Uncover the power of immunisation: